1,485
Views
5
CrossRef citations to date
0
Altmetric
Mini-Review

Revisiting PPARγ as a new friend of GPR120 in the treatment of metabolic disorders

& ORCID Icon
Pages 649-652 | Received 29 Jul 2020, Accepted 15 Sep 2020, Published online: 27 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

David A Fraser, Stephen A Harrison & Detlef Schuppan. (2022) Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH. Expert Opinion on Investigational Drugs 31:12, pages 1269-1278.
Read now

Articles from other publishers (4)

Maxwell Duah, Kexin Zhang, Yiwen Liang, Vivian Adiila Ayarick, Kailin Xu & Bin Pan. (2023) Immune regulation of poly unsaturated fatty acids and free fatty acid receptor 4. The Journal of Nutritional Biochemistry 112, pages 109222.
Crossref
Kazuo Nakamoto & Shogo Tokuyama. (2022) Docosahexaenoic Acid Attenuates the Progression of Nonalcoholic Steatohepatitis by Suppressing the Adipocyte Inflammation via the G Protein-Coupled Receptor 120/Free Fatty Acid Receptor 4 Pathway. Pharmacology 107:5-6, pages 330-338.
Crossref
Gage M Stuttgen & Daisy Sahoo. (2021) FFAR4: A New Player in Cardiometabolic Disease?. Endocrinology 162:8.
Crossref
Mengjiao Wu, Qingfei Li, Kangsen Mai & Qinghui Ai. (2021) Regulation of Free Fatty Acid Receptor 4 on Inflammatory Gene Induced by LPS in Large Yellow Croaker (Larimichthys crocea). Frontiers in Immunology 12.
Crossref